Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2842-39-9

Post Buying Request

2842-39-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2842-39-9 Usage

Chemical Properties

Clear colorless liquid

Check Digit Verification of cas no

The CAS Registry Mumber 2842-39-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,4 and 2 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2842-39:
(6*2)+(5*8)+(4*4)+(3*2)+(2*3)+(1*9)=89
89 % 10 = 9
So 2842-39-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H15NO/c9-6-5-8-7-3-1-2-4-7/h7-9H,1-6H2

2842-39-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(cyclopentylamino)ethanol

1.2 Other means of identification

Product number -
Other names 2-(cyclopentylamino)ethan-1-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2842-39-9 SDS

2842-39-9Downstream Products

2842-39-9Relevant articles and documents

LIPID NANOPARTICLE COMPOSITION

-

Paragraph 00387, (2021/10/15)

Provided herein are lipids that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid molecules) for therapeutic or prophylactic purposes, including vaccination.

CHEMICAL COMPOUNDS

-

Page 197, (2010/02/09)

Quinazoline derivatives of formula (I); for use in the treatment of proliferative diseases such as cancer and in the preparation of medicaments for use in the treatment of proliferative diseases, and to processes for their preparation, as well as pharmaceutical compositions containing them as active ingredient.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2842-39-9